These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

334 related items for PubMed ID: 7834185

  • 1. Potent contractile actions of prostanoid EP3-receptor agonists on human isolated pulmonary artery.
    Qian YM, Jones RL, Chan KM, Stock AI, Ho JK.
    Br J Pharmacol; 1994 Oct; 113(2):369-74. PubMed ID: 7834185
    [Abstract] [Full Text] [Related]

  • 2. Investigation of the prostaglandin E (EP-) receptor subtype mediating relaxation of the rabbit jugular vein.
    Lawrence RA, Jones RL.
    Br J Pharmacol; 1992 Apr; 105(4):817-24. PubMed ID: 1324050
    [Abstract] [Full Text] [Related]

  • 3. Potentiation of aggregation and inhibition of adenylate cyclase in human platelets by prostaglandin E analogues.
    Matthews JS, Jones RL.
    Br J Pharmacol; 1993 Feb; 108(2):363-9. PubMed ID: 8448586
    [Abstract] [Full Text] [Related]

  • 4. Pharmacological studies on prostanoid receptors in the rabbit isolated saphenous vein: a comparison with the rabbit isolated ear artery.
    Lydford SJ, McKechnie KC, Dougall IG.
    Br J Pharmacol; 1996 Jan; 117(1):13-20. PubMed ID: 8825337
    [Abstract] [Full Text] [Related]

  • 5. Characterization of receptors involved in the direct and indirect actions of prostaglandins E and I on the guinea-pig ileum.
    Lawrence RA, Jones RL, Wilson NH.
    Br J Pharmacol; 1992 Feb; 105(2):271-8. PubMed ID: 1559125
    [Abstract] [Full Text] [Related]

  • 6. Characterization of the prostanoid receptor(s) on human blood monocytes at which prostaglandin E2 inhibits lipopolysaccharide-induced tumour necrosis factor-alpha generation.
    Meja KK, Barnes PJ, Giembycz MA.
    Br J Pharmacol; 1997 Sep; 122(1):149-57. PubMed ID: 9298541
    [Abstract] [Full Text] [Related]

  • 7. Characterization of a prostanoid EP3-receptor in guinea-pig aorta: partial agonist action of the non-prostanoid ONO-AP-324.
    Jones RL, Qian YM, Chan KM, Yim AP.
    Br J Pharmacol; 1998 Nov; 125(6):1288-96. PubMed ID: 9863659
    [Abstract] [Full Text] [Related]

  • 8. Characterization of the prostanoid receptors mediating inhibition of PAF-induced aggregation of guinea-pig eosinophils.
    Teixeira MM, al-Rashed S, Rossi AG, Hellewell PG.
    Br J Pharmacol; 1997 May; 121(1):77-82. PubMed ID: 9146890
    [Abstract] [Full Text] [Related]

  • 9. Characterization of EP-receptor subtypes involved in allodynia and hyperalgesia induced by intrathecal administration of prostaglandin E2 to mice.
    Minami T, Nishihara I, Uda R, Ito S, Hyodo M, Hayaishi O.
    Br J Pharmacol; 1994 Jul; 112(3):735-40. PubMed ID: 7921597
    [Abstract] [Full Text] [Related]

  • 10. Characterization of the prostaglandin E2 sensitive (EP)-receptor in the rat isolated trachea.
    Lydford SJ, McKechnie K.
    Br J Pharmacol; 1994 May; 112(1):133-6. PubMed ID: 8032634
    [Abstract] [Full Text] [Related]

  • 11. Prostanoid EP(1)- and TP-receptors involved in the contraction of human pulmonary veins.
    Walch L, de Montpreville V, Brink C, Norel X.
    Br J Pharmacol; 2001 Dec; 134(8):1671-8. PubMed ID: 11739243
    [Abstract] [Full Text] [Related]

  • 12. Binary regulation of interleukin (IL)-6 production by EP1 and EP2/EP4 subtypes of PGE2 receptors in IL-1beta-stimulated human gingival fibroblasts.
    Noguchi K, Shitashige M, Endo H, Kondo H, Ishikawa I.
    J Periodontal Res; 2002 Feb; 37(1):29-36. PubMed ID: 11842936
    [Abstract] [Full Text] [Related]

  • 13. A novel inhibitory prostanoid receptor in piglet saphenous vein.
    Coleman RA, Grix SP, Head SA, Louttit JB, Mallett A, Sheldrick RL.
    Prostaglandins; 1994 Feb; 47(2):151-68. PubMed ID: 8016385
    [Abstract] [Full Text] [Related]

  • 14. Interaction of prostanoid EP₃ and TP receptors in guinea-pig isolated aorta: contractile self-synergism of 11-deoxy-16,16-dimethyl PGE₂.
    Jones RL, Woodward DF.
    Br J Pharmacol; 2011 Jan; 162(2):521-31. PubMed ID: 20955363
    [Abstract] [Full Text] [Related]

  • 15. Identification in human airways smooth muscle cells of the prostanoid receptor and signalling pathway through which PGE2 inhibits the release of GM-CSF.
    Clarke DL, Belvisi MG, Catley MC, Yacoub MH, Newton R, Giembycz MA.
    Br J Pharmacol; 2004 Apr; 141(7):1141-50. PubMed ID: 15023863
    [Abstract] [Full Text] [Related]

  • 16. SC-46275: a potent and highly selective agonist at the EP3 receptor.
    Savage MA, Moummi C, Karabatsos PJ, Lanthorn TH.
    Prostaglandins Leukot Essent Fatty Acids; 1993 Dec; 49(6):939-43. PubMed ID: 8140121
    [Abstract] [Full Text] [Related]

  • 17. In vitro characterization of prostanoid EP-receptors in the non-pregnant human myometrium.
    Senior J, Marshall K, Sangha R, Baxter GS, Clayton JK.
    Br J Pharmacol; 1991 Mar; 102(3):747-53. PubMed ID: 1285399
    [Abstract] [Full Text] [Related]

  • 18. Characterization of the PGE receptor subtype mediating inhibition of superoxide production in human neutrophils.
    Talpain E, Armstrong RA, Coleman RA, Vardey CJ.
    Br J Pharmacol; 1995 Apr; 114(7):1459-65. PubMed ID: 7606349
    [Abstract] [Full Text] [Related]

  • 19. Stimulatory (EP1 and EP3) and inhibitory (EP2) prostaglandin E2 receptors in isolated ileal smooth muscle cells.
    Botella A, Delvaux M, Fioramonti J, Frexinos J, Bueno L.
    Eur J Pharmacol; 1993 Jun 11; 237(1):131-7. PubMed ID: 7689467
    [Abstract] [Full Text] [Related]

  • 20. Ligand binding specificities of the eight types and subtypes of the mouse prostanoid receptors expressed in Chinese hamster ovary cells.
    Kiriyama M, Ushikubi F, Kobayashi T, Hirata M, Sugimoto Y, Narumiya S.
    Br J Pharmacol; 1997 Sep 11; 122(2):217-24. PubMed ID: 9313928
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.